Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 62,213 | 59,148 | 58,316 | 61,793 | 52,048 |
| Cost of Goods | 15,901 | 18,929 | 17,580 | 18,968 | 20,391 |
| Gross Profit | 46,312 | 40,219 | 40,736 | 42,825 | 31,657 |
| Operating Expenses | 42,104 | 39,330 | 37,975 | 35,873 | 33,033 |
| Operating Income | 5,109 | 1,818 | 3,341 | 7,920 | -985 |
| Interest Expense | 1,905 | 1,940 | 1,996 | 2,055 | 2,037 |
| Other Income | 163 | 169 | -33 | 110 | 18 |
| Pre-tax Income | 3,367 | 47 | 1,312 | 5,975 | -3,004 |
| Income Tax | 281 | 39 | 52 | N/A | N/A |
| Net Income Continuous | 3,086 | 8 | 1,260 | 5,802 | -3,004 |
| Net Income | $3,086 | $8 | $1,260 | $5,802 | $-3,004 |
| EPS Basic Total Ops | 0.08 | 0.00 | 0.03 | 0.17 | -0.08 |
| EPS Basic Continuous Ops | 0.08 | 0.00 | 0.03 | 0.18 | -0.08 |
| EPS Diluted Total Ops | 0.08 | 0.00 | 0.03 | 0.17 | -0.08 |
| EPS Diluted Continuous Ops | 0.08 | 0.00 | 0.03 | 0.18 | -0.08 |
| EBITDA(a) | $9,081 | $5,743 | $7,241 | $11,784 | $2,564 |